{
    "nct_id": "NCT03280836",
    "official_title": "Women In Steady Exercise Research - Neoadjuvant Exercise Trial",
    "inclusion_criteria": "3.1 Inclusion Criteria\n\n* Women with a breast cancer diagnosis (Stage I-IIIC)\n* Sedentary (< 75 min/wk of moderate intensity exercise over the past month)\n* No previous history of anthracycline based chemotherapy\n* Absence of heart disease (clinical diagnosis of coronary artery disease, arrhythmias, congenital heart defects, dilated cardiomyopathy, or valvular heart disease)\n* Absence of contraindications for neoadjuvant chemotherapy\n* Scheduled to receive neoadjuvant chemotherapy\n* Primary attending oncologist approval\n\n3.2 Exclusion Criteria\n\n* Absolute contraindications for exercise stress testing\n\n  * acute myocardial infarction (3-5 days)\n  * unstable angina\n  * uncontrolled arrhythmias causing symptoms or hemodynamic compromise\n  * syncope\n  * acute endocarditis\n  * acute myocarditis or pericarditis\n  * uncontrolled heart failure\n  * acute pulmonary embolus or pulmonary infarction\n  * thrombosis of lower extremities\n  * suspected dissecting aneurysm\n  * uncontrolled asthma\n  * pulmonary edema\n  * room air desaturation at rest â‰¤85%\n  * respiratory failure\n  * acute noncardiopulmonary disorder that may affect exercise performance or be aggravated by exercise\n  * mental impairment leading to inability to cooperate\n  * decisional impairment\n* Non-English speaking\n* Women only diagnosed with ductal carcinoma in situ\n* Women diagnosed with stage 4 metastatic breast cancer\n* Pregnant women\n* Men\n* Children\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 21 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}